Novartis Drug Tasigna(R) Receives FDA Priority Review for Newly Diagnosed Patients With Early-Stage Chronic Myeloid …
Novartis announced today that Tasigna® 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Andrew Jackson Jihad, “Brave as a Noun/Survival Song” @ Asbury Lanes, Asbury Park NJ

Survival: $12.91 Survival

Dinner Survival $15.6 Dinner Survival

Survival $7.99 6131 Records:10

The U.S. Army Survival Manual: $8.36 The U.S. Army Survival Manual

Comments are closed